5326 - 5350 of 7916 Results
Title
Year
-
OPENTitle: Phosphorylation of Parkin at serine 65 is essential for its activationin vivoJournal Name: Open BiologyPublisher: The Royal SocietyVol: 8Issue #: 11Start Page: 180108End Page: 180108Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.180108Best OA location URL: https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.180108Citation Count: 102
-
OPENTitle: Predicting early cognitive decline in newly-diagnosed Parkinson's patients: A practical modelJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 56Issue #:Start Page: 70End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.031Best OA location URL: https://europepmc.org/articles/pmc6425482?pdf=renderCitation Count: 23
- The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN212018OPENTitle: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21Journal Name: Cell ReportsPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 2484End Page: 2496.e9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002Best OA location URL: http://www.cell.com/article/S2211124718317315/pdfCitation Count: 32
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice2018OPENTitle: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in miceJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066Best OA location URL: https://stm.sciencemag.org/content/scitransmed/10/465/eaah4066.full.pdfCitation Count: 623
-
OPENTitle: Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s DiseaseJournal Name: MetabolitesPublisher: MDPI AGVol: 8Issue #: 4Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo8040071Best OA location URL: https://www.mdpi.com/2218-1989/8/4/71/pdfCitation Count: 42
-
OPENTitle: The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohortJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 12Start Page: 1460End Page: 1477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.644Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.644Citation Count: 394
-
OPENTitle: The vermiform appendix impacts the risk of developing Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280Best OA location URL: https://stm.sciencemag.org/content/scitransmed/10/465/eaar5280.full.pdfCitation Count: 232
-
OPENTitle: δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer’s diseaseJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 2Start Page: 586End Page: 603Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0286-zBest OA location URL: https://europepmc.org/articles/pmc6684859?pdf=renderCitation Count: 61
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 49
-
OPENTitle: Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammationJournal Name: GliaPublisher: WileyVol: 66Issue #: 11Start Page: 2427End Page: 2437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/glia.23482Best OA location URL: https://europepmc.org/articles/pmc6275110?pdf=renderCitation Count: 46
- The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis2018OPENTitle: The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early DiagnosisJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00326Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00326/pdfCitation Count: 77
-
RESTRICTEDTitle: The Linked Clinical Trials initiative (LCT) for Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 307End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14175Citation Count: 17
- Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 42018OPENTitle: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1337-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1337-8Citation Count: 35
-
OPENTitle: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-34490-9Best OA location URL: https://www.nature.com/articles/s41598-018-34490-9.pdfCitation Count: 119
-
RESTRICTEDTitle: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1961End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27523Citation Count: 42
-
OPENTitle: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of eventsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 67Issue #:Start Page: 224End Page: 229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018Best OA location URL: https://europepmc.org/articles/pmc6287952?pdf=renderCitation Count: 29
-
OPENTitle: Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 15Issue #: 2Start Page: 232End Page: 244Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.08.012Best OA location URL: https://pure.eur.nl/files/48163974/Repub_115206_O-A.pdfCitation Count: 233
-
OPENTitle: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathiesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 28Issue #: 4Start Page: 548End Page: 560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy365Best OA location URL: https://academic.oup.com/hmg/article-pdf/28/4/548/27636558/ddy365.pdfCitation Count: 59
-
OPENTitle: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 144Issue #:Start Page: 19End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013Best OA location URL: https://europepmc.org/articles/pmc6286225?pdf=renderCitation Count: 49
-
OPENTitle: Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-33921-xBest OA location URL: https://www.nature.com/articles/s41598-018-33921-x.pdfCitation Count: 89
-
OPENTitle: Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse BrainJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 11Issue #: 5Start Page: 1156End Page: 1170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.09.004Best OA location URL: http://www.cell.com/article/S2213671118303898/pdfCitation Count: 42
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://europepmc.org/articles/pmc6261681?pdf=renderCitation Count: 18
-
OPENTitle: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage InferenceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-018-05892-0Best OA location URL: https://www.nature.com/articles/s41467-018-05892-0.pdfCitation Count: 343
-
OPENTitle: Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s DiseaseJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 212End Page: 224Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-018-0981-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-018-0981-y.pdfCitation Count: 17
-
OPENTitle: Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00318Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00318/pdfCitation Count: 64